Orso Bio reported raising $84.6 Million in an initial SEC Form D filing, from an offering of $84.6 Million
Round Type
Venture
Menlo ParkBiotechnologyHealth CareBiopharmaWho else raised in Biopharma and Biotechnology around the same time
Companies in the same sectors as OrsoBio that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $700K on December 8, 2023.
- Cartesian Therapeutics, Inc. raised $60M on November 13, 2023.
- Forward Therapeutics raised $50M (Series A) on November 8, 2023.
- Gyre Therapeutics raised $5M on October 30, 2023.
- Aligos Therapeutics raised $92M on October 25, 2023.
- Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
Who to call at OrsoBio, and when
A new round usually means OrsoBio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day OrsoBio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OrsoBio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OrsoBio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OrsoBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
OrsoBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.